Executive Committee (June 2019 – June 2021)

• President：Liang Li

  Professor Liang Li, University of Alberta, Edmonton, Alberta, Canada

  Dr. Li obtained his BSc in Chemistry from Zhejiang (Hangzhou) University in 1983 and his PhD from the University of Michigan, Ann Arbor, Michigan and joined the University of Alberta in July 1989, where he is Professor of Chemistry and Adjunct Professor of Biochemistry. He is

  an elected fellow of the Royal Society of Canada (Academy of Science) (2019). He is a Co-Director of the Metabolomics Innovation Centre (TMIC) of Canada since 2019. Dr. Li was Tier 1 Canada Research Chair in Analytical Chemistry from 2005 to 2019. He served as Director, Alberta Cancer Board Proteomics Resource Laboratory, from 2000 to 2005. He was Chair of Analytical Chemistry Division at the University of Alberta from 2007 to 2019. He was a Co-PI of the Human Metabolome Database (HMDB) Project; his laboratory generated the HMDB MS/MS spectral library of the endogenous human metabolites which has been widely used by the metabolomics community. His laboratory is a pioneer in developing the high-performance chemical isotope labeling liquid chromatography mass spectrometry (HP-CIL LC-MS) platform for quantitative and comprehensive metabolome profiling of bio-systems. Dr. Li has received a number of national and international awards and honors. He is an editor of Analytica Chimica Acta, an international journal on analytical chemistry, since 2005. He is also a member of the editorial advisory board in a number of scientific journals.

  More >>

• President-elect：Lan Huang

  

  Lan Huang is Professor of Physiology & Biophysics in School of Medicine, University of California, Irvine. Her research focuses on developing novel, integrated mass spectrometry-based proteomic strategies to characterize dynamic proteomes of macromolecular protein complexes

  and understand their functions, particularly those in the ubiquitin-proteasome system. Through the years, the Huang lab has developed various novel methodologies to capture, purify and quantify protein-protein interactions of protein complexes in living cells. In addition, her lab has developed a new class of cross-linking reagents, i.e. sulfoxide-containing MS-cleavable cross-linkers (e.g. DSSO), and thus established a robust cross-linking mass spectrometry (XL-MS) platform enabling fast and accurate identification of cross-linked peptides. These XL-MS strategies have been successfully employed to determine protein interaction interfaces and derive structural topologies of protein complexes in vitro and in vivo. The strategies developed by her group have proven highly effective as general proteomic tools for studying protein complexes. She has co-authored more than 120 peer-reviewed research articles. She has served on multiple committees for professional societies including ASMS, ASBMB, US HUPO and CASMS organizations. She has been an Ad hoc reviewer for many journals and funding agencies, and currently serves on NIH study section. She has served as co-organizers for numerous international conferences including US HUPO annual meeting (2015 and 2020), ASMS Sanibel meeting (2019), and Gordon conferences (2015 & 2017). She has been an Editorial Board member of Molecular & Cellular Proteomics since 2007 and an Associate Editor for FASEB BioAdvances since 2019.

  More >>

• Immediate Past President：Andy TAO

  Weiguo Andy Tao, Ph.D., Former President (2017-2019)
  Professor in Biochemistry and Chemistry, Purdue University

  Prof. W. Andy Tao leads an active research group focusing on new developments in proteome analyses using systems biology approaches. He received his mass spectrometry training through his dissertation work on gas-phase chiral analysis in the Aston Lab at Purdue University,

  headed by Dr. R. Graham Cooks. After receiving his Ph.D. in December 2001, he became a Damon Runyon Postdoctoral Fellow in the Institute for Systems Biology at Seattle, under the supervision of Drs. Leroy Hood and Ruedi Aebersold. He started his own research group in the Department of Biochemistry at Purdue University in 2005, and currently is Professor in ranking. He also has joined appointments in the Department of Chemistry, Department of Medicinal Chemistry & Molecular Pharmacology, Purdue University, Southeast University (SEU), Nanjing, and Shanghai Institute of Stress Biology, Chinese Academy of Science (CAS).

  More >>

• Vice President：Yinsheng Wang

  

  Dr. Wang is a Distinguished Professor in the Chemistry Department of the University of California Riverside. The current interests of his research group encompass the development and applications of mass spectrometric methods for studying modified nucleic acids as well as

  nucleotide- and nucleic acid-binding proteins.

  More >>

• Vice President：Naidong Weng

  

  Dr. Weng is Scientific Director, Janssen Fellow, and Head of Bioanalytical Chemistry and Pharmacokinetics, Discovery Sciences, Janssen Research & Development, Johnson and Johnson, Spring House, PA, USA. Currently he supervises a department which has end to end responsibilities

  for LC-MS bioanalysis (discovery and development). The research interests of his group include LC-MS bioanalysis of drug candidates, metabolites, biomarkers, conjugated proteins/peptides, oligonucleotides, and more recently metabolomics. Dr. Weng has over 110 peer-reviewed journal publications and book chapters. He co-edited two books on bioanalysis (Eliminating bottlenecks for efficient bioanalysis: practices and applications in drug discovery and development, 2014; Targeted biomarker quantitation by LC-MS, 2017) and one Special Focus Issue of Bioanalysis on Bioanalytical Laboratory Structure and Management (2014). He has been teaching short courses on DMPK at ASMS since 2011. He is the current US regional editor for Biomedical Chromatography (Wiley).

  More >>

• Treasurer：Shouxun Zhao

  

  Dr. Shouxun Zhao is a technical manager at BASF leading all Structure Elucidation activities at BASF Corporate Analytics Division using Mass Spectrometry, NMR, FTIR, UV-Vis and Raman techniques for unknown identification and trace quantitative analysis in North America region.

  He oversees analytical projects to support R&D activities, production issues, product technical services and global regulatory compliance submissions within BASF. In addition, he also manages project collaborations across BASF globally. He received his Bachelor's and Master’s degree from Department of Chemistry, Tsinghua University in Beijing, China, and his Ph.D. degree majoring Environmental Health & Toxicology from SUNY Albany. Before he joined industry, he completed his post-doctoral training at Mount Sinai School of Medicine in New York City.

  More >>

• Secretary & Webmaster：Zezong Gu

  

  顧澤宗博士，美國密蘇里大學 (University of Missouri, MU) 醫學院終身教授，神經科學轉化醫學中心創造者之一，博士生導師。1985年畢業於天津醫科大學，1999年獲美國德州大學Galveston 醫學院細胞生物學與神經科學博士學位。同年在Sanford Burnham Prebys Medical Discovery Institute从事博士後研究，晉升研究員，助理教授。

  2007邀聘美國密蘇里大學醫學院任助理教授、副教授并获终身教授资格。主要从事Aging，蛋白翻譯後修飾與神經退行性病變 (PTM/neurodegeneration) 的研究，尤其在氧/氮 (自由基) 應激反應 (oxidative/nitrosative stress) 的作用機理，分子影像及轉化應用研究。他在蛋白組學研究的技術建立，包括質譜分析技術，應用到神經損傷，神經退行性疾病，以及藥用植物及其有效成分的作用機理和轉化。他的研究工作有望在神經損傷，腦創傷，腦卒中，Alzheimer等疾病的診斷和治療中做出重要貢獻。這些工作被國際同行認可，已在包括Science，Nature，Neuron，PNAS 等國際學術刊物上發表70餘篇論文，單篇引用高達1000多次。所做科研獲得美國聯邦政府以及基金會資助，包括國立衛生研究院 (NIH)，國防部 (DOD)，聯邦退伍軍人健康管理局 (VHD)，美國心臟協會 (AHA)，The Dana Foundation，國家橄欖球聯盟 (NFL) 基金會，Missouri和Indiana州腦脊髓損傷疾病研究項目等。更多介紹參考https://medicine.missouri.edu/faculty/zezong-gu-md-phd/。顧博士科研與教學並重，在MU醫學院，研究生院兼任教學。在他的指導下，研究室已培養了40多名研究生，博士後和訪學，包括從中國，Mexico，Puerto Rico，India，Turkey，Israel，Libya，C ôte d’Ivoire，Ghana，Nigeria，Cameroon和South Africa等國家與地區。另外每年還有多名高年級本科生在他的指導下，進入醫學院學習或科研領域。顧博士熱心公益，自2009以來服務與美國華人質譜學會 (CASMS)，歷任Chair of Memberhip & Member Connections Committee (2009-2011); Executive Committee members和Secretary and Webmaster (2011-present)。

  More >>